期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肥厚型梗阻性心肌病室间隔心肌消融术中国专家共识 被引量：17

暂未订购
导出
摘要 在消融前,确保球囊在测试过程中没有移位,封堵压力无衰减,临时起搏工作良好.然后,为减轻患者胸痛,消融前10～15 min 静脉注射吗啡5～10 mg.并根据间隔支动脉及其支配供血区域的大小,初步判断无水酒精的用量.经球囊中心腔连续缓慢均速（0.5～1.0 ml/min）注入96%～99% 无水酒精1～2 ml（实际注射入间隔支的剂量）.若压差无变化,且无AVB 发生,可适度增加酒精注入量,但须注意无水酒精用量越少越安全.注射酒精推力不宜太大,整个过程应在X 线透视下进行,以防充盈的球囊弹出误将酒精注入LAD.推注酒精时应避免回抽动作,以防球囊中心腔凝血.同时应严密观察患者的血压、LVOTG 和心电图变化（心率、心律、ST-T 等）及胸痛的严重程度,注射过程中出现AVB 或严重室性心律失常或血液动力学变化时应立即暂停注射.……参考文献：[1]Kimmelstiel C,Krishnamurthy B,Weintraub A,et al.Alchohol septal ablation and hypertrophic cardiomyopathy.Chin J Cardiol,2009,37：1074-1077.
作者 肥厚型梗阻性心肌病室间隔心肌消融术中国专家共识组
出处 《中国医药科学》 2012年第10期3-4,共2页 China Medicine And Pharmacy
关键词 肥厚型梗阻性心肌病 室间隔心肌消融术 严重室性心律失常 血液动力学变化 无水酒精 静脉注射 专家 中国
分类号 R542.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

  • 1Gietzen F,Ieuner C,Gerenkamp T,et al.Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of first septal branch of left coronary[].European Heart Journal.1994
  • 2Sigwart U,Gribic M,Payor M, et al.Wall motion during balloon occlusion[].Ventricular wall motion.1983
  • 3Waller BF,Maron BJ,Epstein SE,et al.Transmural Myocardial infarction in hy-pertrophic cardiomyopathy: a cause ofconversion from left ventricular asymme-try to symmetry and from normal-sized todilated left ventricular cavity[].Chest.1981
  • 4Carey Kimmelstiel Barath Krishnamurthy Andrew Weintraub Navin Kapur.酒精室间隔消融术与肥厚型心肌病[J].中华心血管病杂志,2009,37(12):1074-1077. 被引量：8

二级参考文献19

  • 1Boekstegers P, Steinbigler P, Molnar A, et al. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001, 38:846-853.
  • 2Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:resuhs with respect to intraprocedural myocardial contrast echocardiography. Circulation, 1998,98:2415-2421.
  • 3Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation, 2004, 109:452-456.
  • 4Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol, 2006,19:319-327.
  • 5Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol,2001, 38:1994-2000.
  • 6Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001, 38 : 1701-1706.
  • 7Firoozi S, Elliott PM, Sharma 5, et at. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical haemodynamic and exercise outcomes. Eur Heart J, 2002,23: 1617-1624.
  • 8van der Lee C, ten Cate FJ, Geleijnse MC, et al. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation ,2005, 112:482-488.
  • 9Maron B J, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coil Cardiol, 2003,42 : 1687-1713.
  • 10Sorajja P, Valeti U, Nishimura RA, et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation ,2008,118 : 131-139.

共引文献7

同被引文献70

  • 1中国医师协会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会,张健,黄峻.中国肥厚型心肌病管理指南2017[J].中华心力衰竭和心肌病杂志（中英文）,2017,1(2):65-86. 被引量：39
  • 2乔树宾,高润霖,尤士杰,袁建松,陈纪林,杨跃进.经皮室间隔化学消融术治疗肥厚梗阻型心肌病[J].中华内科杂志,2006,45(3):210-212. 被引量：13
  • 3李靖,刘延玲,何青,乔树宾,凤伟,吕秀章,朱振辉,凌雁,王剑鹏.肥厚型梗阻性心肌病经皮经腔间隔心肌消融术与室间隔心肌切除术疗效比较[J].中华心血管病杂志,2006,34(8):695-698. 被引量：9
  • 4邢杨波,郭航远,王平,游斌权,陈君柱.肥厚型梗阻性心肌病经皮腔内室间隔消融术对心电图及自主神经功能的影响[J].中华心血管病杂志,2007,35(8):731-734. 被引量：1
  • 5Lopes LR, Zekavati A, Syrris P, et al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequen - cing[J]. J Med Genet, 2013, 50: 228-239.
  • 6McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death[J]. Arch Dis Child, 1984, 59: 971-975,.
  • 7Stewart JT, McKenna WJ. Management of arrhythmias in hypertrophic cardiomyopathy[J]. Cardiovasc Drugs Ther, 1994, 8: 95 -99.
  • 8Mamn BJ, Maron MS. Hypertrophic cardiomyopathy[J]. Lancet, 2013, 381: 242-255.
  • 9Kimmelstiel C, Krishnamurthy B, Weintraub A, et al. Alcohol septal ablation and hypertrophic cardiomyopathy [J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2009, 37: 1074-1077.
  • 10Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines[J]. J Am Coll Cardiol, 2005, 42: 1687-1713.

引证文献17

二级引证文献36

中国医药科学
2012年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部